Soft and Condensed Nanoparticles and Nanoformulations for Cancer Drug Delivery and RepurposeWen Yang, Pu Chun Ke, Hanitrarimalala Veroniaina et al.|Advanced Therapeutics|2019Cited by 43
3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinibIsmail M. Meraz, Jack A. Roth, Lihui Gao et al.|Communications Biology|2023Cited by 11